For citations:
Titov K.S., Epifanova M.V., Alimov A.A., Shutov E.V., Nesterova O.Yu., Lebedev S.S., Zapirov G.M. Assessment of kidney injury during immune-targeted therapy (pembrolizumab + axitinib) in patients with metastatic renal cell carcinoma and solitary kidney. Cancer Urology. 2025;21(2):33-41. (In Russ.) https://doi.org/10.17650/1726-9776-2025-21-2-33-41